Agenovir's Incubator/Accelerator Round

Agenovir raised a round of funding on September 21, 2015. Investors include JLabs.

Agenovir is a player in the research and development of a novel class of human therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. The individuals affe…

Articles about Agenovir's Incubator/Accelerator Round: